These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12699680)

  • 41. Rapid deswelling response of poly(N-isopropylacrylamide)/poly(2-alkyl-2-oxazoline)/poly(2-hydroxyethyl methacrylate) hydrogels.
    David G; Simionescu BC; Albertsson AC
    Biomacromolecules; 2008 Jun; 9(6):1678-83. PubMed ID: 18481892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.
    Yee RW
    Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and evaluation of ophthalmic preparations of acetazolamide.
    Kaur IP; Singh M; Kanwar M
    Int J Pharm; 2000 Apr; 199(2):119-27. PubMed ID: 10802405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
    Cheng YH; Tsai TH; Jhan YY; Chiu AW; Tsai KL; Chien CS; Chiou SH; Liu CJ
    Carbohydr Polym; 2016 Jun; 144():390-9. PubMed ID: 27083831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.
    Hsu KH; Gupta K; Nayaka H; Donthi A; Kaul S; Chauhan A
    Pharm Res; 2017 Dec; 34(12):2862-2872. PubMed ID: 29067592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.
    Giuffrida S; Bucolo C; Drago F
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):527-34. PubMed ID: 14733710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
    Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z
    Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiglaucoma ophthalmic agents with prolonged action based on macromolecular excipients. 2. In vivo studies].
    Pergande G; Keipert S; Klatt A
    Pharmazie; 1990 Jul; 45(8):587-91. PubMed ID: 2080204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coaxial nanotubes of stimuli responsive polymers with tunable release kinetics.
    Armagan E; Ozaydin Ince G
    Soft Matter; 2015 Nov; 11(41):8069-75. PubMed ID: 26333009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucoadhesive properties of nanogels based on stimuli-sensitive glycosaminoglycan-graft-pNIPAAm copolymers.
    Pilipenko I; Korzhikov-Vlakh V; Valtari A; Anufrikov Y; Kalinin S; Ruponen M; Krasavin M; Urtti A; Tennikova T
    Int J Biol Macromol; 2021 Sep; 186():864-872. PubMed ID: 34274401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug delivery systems for topical ophthalmic medication.
    Halberg GP; Kelly SE; Morrone M
    Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of degree of crosslinking on 5-fluorouracil release from poly(2-hydroxyethyl methacrylate) hydrogels.
    García O; Trigo RM; Blanco MD; Teijón JM
    Biomaterials; 1994 Jul; 15(9):689-94. PubMed ID: 7948591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incorporation of drug particles for extended release of Cyclosporine A from poly-hydroxyethyl methacrylate hydrogels.
    Kapoor Y; Dixon P; Sekar P; Chauhan A
    Eur J Pharm Biopharm; 2017 Nov; 120():73-79. PubMed ID: 28823714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
    Wang Y; Challa P; Epstein DL; Yuan F
    Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System.
    Pek YS; Wu H; Mohamed ST; Ying JY
    Adv Healthc Mater; 2016 Nov; 5(21):2823-2831. PubMed ID: 27616466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery.
    Liu Y; Liu J; Zhang X; Zhang R; Huang Y; Wu C
    AAPS PharmSciTech; 2010 Jun; 11(2):610-20. PubMed ID: 20354916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.